{"id":6421,"name":"Averin Capital","slug":"bedford-bridge","website":"https://www.averincapital.com","hqGeo":"New York, United States","stageFocus":[],"sectorTags":["AI / ML","Healthcare"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"Averin Capital is an early-stage venture capital firm investing in AI and breakthrough technologies transforming human health. Founded in 2024 by David and Eric Berry, the firm combines technology judgment, scientific and medical expertise, and firsthand company-building experience.","thesisNarrative":"Averin Capital is an early-stage venture capital firm headquartered in New York, United States, with a focus on investing in artificial intelligence and breakthrough technologies that are transforming human health. Founded in 2024 by David and Eric Berry, the firm leverages its deep domain expertise and firsthand company-building experience to support ambitious founders. Averin Capital's investment strategy centers on sectors such as AI/ML, healthcare, and robotics, with a particular emphasis on technologies that reshape human health.\n\nThe firm has a portfolio of six companies, predominantly in the healthcare sector, including Mendaera, Hologen AI, Pine Park Health, Biolinq, CandidPro, and Freenome. Averin Capital's team, comprising founders, operators, physicians, scientists, healthcare executives, and finance leaders, collaborates to evaluate technical, scientific, commercial, and company-building questions. With $500 million in assets under management, Averin Capital aims to empower exceptional teams to unlock their fullest potential and navigate challenges with confidence.","logoUrl":null,"aumUsd":500000000,"submissionUrl":null,"linkedinUrl":"https://www.linkedin.com/company/averin","twitterHandle":null,"portfolio":[{"companyName":"Mendaera","companyUrl":null,"stage":"Early Stage","sector":"Healthcare","investmentYear":2026,"description":"Mendaera combines handheld robotics, ultrasound imaging, and guidance software to help clinicians position needles during medical procedures.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pine Park Health","companyUrl":null,"stage":"Early Stage","sector":"Healthcare","investmentYear":2025,"description":"Pine Park Health brings tech-enabled value based primary care to residents of senior living communities, providing efficient care while meeting patients where they are.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Hologen AI","companyUrl":null,"stage":"Early Stage","sector":"Healthcare","investmentYear":2025,"description":"Hologen builds AI models that combine imaging, genetics, laboratory tests, and medical records to study disease and treatment response.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Biolinq","companyUrl":null,"stage":"Early Stage","sector":"Healthcare","investmentYear":2024,"description":"Biolinq develops wearable glucose-sensing technology, combining glucose, activity, and sleep information with a color-changing indicator.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CandidPro","companyUrl":null,"stage":"Early Stage","sector":"Healthcare","investmentYear":2023,"description":"CandidPro combines doctor-directed clear aligner treatment with clinical support and at-home progress monitoring.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Freenome","companyUrl":null,"stage":"Public","sector":"Healthcare","investmentYear":2023,"description":"Freenome is a publicly traded early cancer detection company (Nasdaq: FRNM). Its FDA-approved SimpleScreen CRC blood test screens for colorectal cancer, with additional cancer screening tests in development.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":6,"partners":[{"id":55043,"name":"Tristan Hunt","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":55044,"name":"Jeffrey Low","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":33182,"name":"Alex Lau","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":33181,"name":"Eric Berry","title":"Managing Partner and Co-Founder","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":55045,"name":"Tomer Zitelny","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":33180,"name":"David Berry","title":"Managing Partner and Co-Founder","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[{"id":1669,"name":"Averin Capital II","vintageYear":2020,"sizeUsd":150000000,"status":"investing","focusAreas":[]},{"id":1668,"name":"Averin Capital I","vintageYear":2018,"sizeUsd":100000000,"status":"fully deployed","focusAreas":[]}],"activity":{"lastInvestmentYear":2026,"investmentsThisYear":1},"activityItems":[{"kind":"investment","title":"Invested in Mendaera","url":null,"source":"portfolio records","occurredAt":"2026-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in Hologen AI","url":null,"source":"portfolio records","occurredAt":"2025-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in Pine Park Health","url":null,"source":"portfolio records","occurredAt":"2025-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in Biolinq","url":null,"source":"portfolio records","occurredAt":"2024-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in Freenome","url":null,"source":"portfolio records","occurredAt":"2023-06-30T00:00:00.000Z"},{"kind":"investment","title":"Invested in CandidPro","url":null,"source":"portfolio records","occurredAt":"2023-06-30T00:00:00.000Z"},{"kind":"fund","title":"Raised Averin Capital II ($150M)","url":null,"source":"fund records","occurredAt":"2020-06-30T00:00:00.000Z"},{"kind":"fund","title":"Raised Averin Capital I ($100M)","url":null,"source":"fund records","occurredAt":"2018-06-30T00:00:00.000Z"}],"contentUpdatedAt":"2026-11-12T19:39:54.914Z","investorType":"vc","preferredApproach":null,"prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":7722,"name":"Sheesha Finance","slug":"sheesha-finance","logoUrl":null,"website":"https://sheeshafinance.gitbook.io/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Fintech"],"hqGeo":null},{"id":13762,"name":"NeuroNet Ventures","slug":"neuronet-ventures","logoUrl":null,"website":"https://neuronetgpo.com/","stageFocus":["Seed"],"sectorTags":["AI / ML"],"hqGeo":"Chicago, IL"},{"id":11767,"name":"LiftScale Partners","slug":"liftscale-partners","logoUrl":null,"website":"https://weareliftscale.com/","stageFocus":["Pre-Seed"],"sectorTags":["AI / ML","SaaS"],"hqGeo":"San Francisco, CA"},{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":1574,"name":"Plaid Ventures","slug":"plaid-ventures","logoUrl":null,"website":"https://plaid.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Fintech","Developer Tools","AI / ML"],"hqGeo":"San Francisco, CA"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"}],"featuredIn":[{"slug":"ai","displayName":"AI & ML Investors","pageType":"industry"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":"Averin Capital is an early-stage venture capital firm based in New York, United States. The firm invests in AI and breakthrough technologies transforming human health.\n\nFounded in 2024 by David and Eric Berry, Averin Capital combines technology judgment, scientific and medical expertise, and firsthand company-building experience. The firm maintains a focus on the AI/ML, healthcare, and robotics sectors.","portfolioNarrative":"Averin Capital has recorded six investments. The earliest recorded investment year is 2023 and the most recent is 2026. The firm has assets under management of 500 million dollars.\n\nIts recorded portfolio includes Mendaera, Hologen AI, Pine Park Health, Biolinq, CandidPro, and Freenome. All portfolio companies except Freenome, which is public, were early-stage healthcare investments at the time of investment.","seoTitle":null,"seoDescription":null,"lastVerifiedAt":null}